Ver­tex wins 'break­through' nod for non-opi­oid pain drug; Af­ter US with­draw­al, EMA re­stricts Clo­vis' Rubra­ca

3 years ago
News Briefing

Astel­las gath­ers scat­tered cell and gene ther­a­py, BD units in new $70M South San Fran­cis­co hub

3 years ago
People
Cell/Gene Tx

Biden to tap Har­vard sur­geon, clin­i­cal tri­als ex­pert as NCI di­rec­tor

3 years ago
People

Ex-Mod­er­na com­mer­cial leader lands at Cel­sion as CEO; Schwan song: Chang­ing of the guard at Roche to take ef­fect next ...

3 years ago
Peer Review

Or­biMed-backed Sil­ver­back, three months af­ter hack­ing the pipeline, re­verse-merges with small al­ler­gy biotech

3 years ago
Deals

VM­LY&R Health adds new man­ag­ing di­rec­tor and cre­ative head, with aims to match phar­mas' pa­tient fo­cus

3 years ago
Pharma
Marketing

Ad­vo­cates call on Vi­iV to low­er price of long-act­ing HIV in­jectable

3 years ago
Pharma

For ac­count­ing pur­pos­es, Bio­gen says its $223M in­ven­to­ry of Aduhelm is ba­si­cal­ly worth­less

3 years ago
Pharma

CBO finds Sen­ate's FDA user fee bill will re­duce the fed­er­al deficit by about $1.4B

3 years ago
FDA+
Law

Roche plots new course for tiragolum­ab as ex­ecs nav­i­gate biosim­i­lar chal­lenges and de­clin­ing Covid-19 sales

3 years ago
Pharma

NHS watch­dog im­pos­es $84M fine on Pfiz­er, Fly­nn Phar­ma in newest de­vel­op­ment of price-goug­ing saga

3 years ago
Pharma

Gilead dou­bles down on HIV pre­ven­tion, treat­ment amid Covid set­backs and await­ing FDA de­ci­sion on long-act­ing ...

3 years ago
Pharma
Marketing

Man­u­fac­tur­ing roundup: mR­NA man­u­fac­tur­er nets $300M+ in­vest­ment to scale re­search; Cy­ti­va ac­quires Michi­gan fa­cil­i­ty

3 years ago
Manufacturing

Biosim­i­lar in­spec­tions still lag­ging as the FDA looks to clear its back­log

3 years ago
FDA+
Manufacturing

The new CEO at Roche has fol­lowed a fa­mil­iar path in­to the C-suite. But it's his next steps that are cru­cial to his ...

3 years ago
Bioregnum

'Like a bul­let­proof vest': Can­cer cells make their own kind of col­la­gen. Can pierc­ing through make treat­ments bet­ter?

3 years ago
R&D
Discovery

Small UK biotech touts long-term da­ta for he­mo­phil­ia B gene ther­a­py as it at­tempts a come­back

3 years ago
R&D
Cell/Gene Tx

Covid-19 roundup: New Omi­cron sub­vari­ant first found in In­dia sparks de­bate on sever­i­ty; Ap­proval for Sh­ionogi's oral ...

3 years ago
Coronavirus

Up­dat­ed: Span­ish he­parin man­u­fac­tur­er draws the ire of the FDA in its lat­est warn­ing over qual­i­ty con­cerns

3 years ago
FDA+
Manufacturing

Con­nect with End­points News — here's our ma­jor event cal­en­dar com­ing up in H2 2022

3 years ago
Publisher's note

Roche trims out some pipeline fail­ures while flag­ging a PhI­II flop for Tecen­triq

3 years ago
R&D

Pfiz­er to make ma­jor in­vest­ment in vac­cine R&D and man­u­fac­tur­ing site in New York

3 years ago
R&D
Manufacturing

X4 slash­es pipeline, lays off staff just three weeks af­ter net­ting a $55M PIPE

3 years ago
People
R&D

Up­dat­ed: Study shows As­traZeneca's Covid-19 mAb Evusheld may not work against dom­i­nant Omi­cron strain

3 years ago
Coronavirus
First page Previous page 492493494495496497498 Next page Last page
A service from the Financial Times